NCT07143513 - Real World Evaluation of Sotorasib Among Chinese Non-Small Cell Lung Cancer Patients | Biotech Hunter

Enrollment

115

Participants

Timeline

Start Date

August 11, 2025

Primary Completion Date

February 28, 2026

Study Completion Date

June 30, 2026

Conditions

Non-Small Cell Lung Cancer

Interventions

DRUG

Sotorasib

Participants will have received sotorasib orally daily until disease progression or unacceptable toxicity.

Trial Locations (3)

RECRUITING

Ruijin-Hainan Hospital Shanghai Jiao Tong University School of Medicine Hainan Boao Research Hospital, Qionghai

RECRUITING

Boao Evergrande International Hospital, Qionghai

RECRUITING

Boao Super Hospital, Qionghai